Skip to main content

$0.260 0.035 (15.56%)

High

$0.26

Low

$0.22

Trades

21

Turnover

$59,559

Volume

239,872
30 June 2023 at 4:10pm
Register to track UBI and receive email alerts.
Subject
UBI Ann: Notification of cessation of securities - UBI

UBI Ann: Application for quotation of securities - UBI

UBI Ann: Application for quotation of securities - UBI

UBI Ann: UBI signs Master Collaboration Agreement with Mayo Clinic

UBI Ann: Investor Presentation

UBI Ann: UBI signs Master Collaboration Agreement with Mayo Clinic

UBI Ann: Appendix 3Y - Craig Coleman

UBI Ann: Form 604 - JM Financial Group Limited

UBI Ann: Q3 2021 Results and Market Update

UBI Ann: Jobkeeper Report

UBI Ann: UBI launches Regulatory Clinical Trial for Xprecia Prime

UBI Ann: UBI signs USA distribution deal and Sentia sales hit $1M

UBI Ann: September 2021 Appendix 4C and Quarterly Activity Report

UBI Ann: UBI receives $2.8M under the R&D Tax Incentive Rebate

UBI Ann: Application for quotation of securities - UBI

UBI Ann: UBI signs major French distribution deal for Sentia

UBI Ann: UBI extends clinical development trials for Tn Antigen

UBI Ann: Form 604 - Jencay Capital Pty Ltd

UBI Ann: Peter Mac - Tn Antigen cancer biosensor trial

UBI Ann: Notification regarding unquoted securities - UBI

UBI Ann: UBI locks in CEO with revised Long-Term Incentive Plan

UBI Ann: Market Update

UBI Ann: Application for quotation of securities - UBI

UBI Ann: Application for quotation of securities - UBI

UBI Ann: Appendix 4D and Half Year Results - 30 June 2021

UBI Ann: June 2021 Quarterly Activity Report and Appendix 4C

UBI Ann: Ceasing to be a substantial holder

UBI Ann: Notification of cessation of securities - UBI

UBI Ann: Application for quotation of securities - UBI

UBI Ann: Results of 2021 Meeting

UBI Ann: CEO's AGM Address to Shareholders

UBI Ann: Change in substantial holding

UBI Ann: Form 604 - Jencay Capital Pty Ltd

UBI Ann: Notification regarding unquoted securities - UBI

UBI Ann: Application for quotation of securities - UBI

UBI Ann: Notification of cessation of securities - UBI

UBI Ann: Sentia Sales Update

UBI Ann: Notice of Meeting/Proxy Statement

UBI Ann: Q1 2021 Results

UBI Ann: UBI signs New Zealand distribution deal for Sentia

UBI Ann: Appendix 4C - quarterly

UBI Ann: UBI signs South Africa distribution deal for Sentia

UBI Ann: Appendix 2A

UBI Ann: UBI signs USA distribution deal for Sentia

UBI Ann: UBI signs Chilean distribution deal for Sentia

UBI Ann: UBI signs exclusive deal with Deakin and Swinburne

UBI Ann: UBI signs global supply agreement for new technology

UBI Ann: UBI signs exclusive agreement for cancer biosensor

UBI Ann: Trading Halt

UBI Ann: Pause in Trading

Register to track UBI and receive email alerts.

Similar Companies

AT1
COH
CSX
CYC
EMV
IBX
IPD
MX1
RSH
SOM